Latest stories on INMB
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
GlobeNewswire63 · neutralgeneral
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
StockTitan58 · neutralgeneral
INmune Bio to Present at the H.C. Wainwright Global Investment Conference
StockTitan55 · neutralgeneral
INmune Bio: CORDStrom In The Lead After Signs Of UK Regulatory Alignment
Seeking Alpha64 · neutralproduct/pr
INmune Bio submits two regulatory packages to EMA for Ebstrocel
The Fly59 · neutralgeneral
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
GlobeNewswire67 · bullishproduct/pr
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
Business Insider63 · neutralproduct/pr
INmune Bio targets Ebstrocel U.K. MAA by end of Q3 or early Q4 2026 while outlining $1M-$1.5M monthly burn
Seeking Alpha53 · neutralgeneral
INmune Bio Inc. (INMB) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
INmune Bio (INMB) Q2 2026 Earnings Call Transcript
Yahoo Top56 · neutralearnings
INmune Bio (INMB) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
INmune Bio, Inc. Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
INmune Bio Q2 Earnings Call Highlights
Yahoo Top58 · neutralearnings
INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
Business Insider56 · neutralgeneral
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
Business Insider50 · neutralgeneral
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
Business Insider59 · neutralgeneral
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
StockTitan59 · neutralgeneral
INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform
StockTitan63 · neutralproduct/pr
INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform
StockTitan63 · neutralproduct/pr
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC | INMB Stock News
StockTitan73 · bullishproduct/pr
INmune Bio Executes Warrant Inducement and Extension Agreement
TipRanks50 · neutralgeneral
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral